Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
B 11 , 26552669 (2021)
Se trata del primer medicamento que acta simultneamente en dos receptores hormonales: el receptor de GLP-1 (pptido similar al glucagn tipo 1) y el receptor de GIP (polipptido insulinotrpico dependiente de glucosa)
doi: 10.1001/jamanetworkopen.2024.33326
Chemotherapy-Induced Polyneuropathy Chemotherapy-induced peripheral polyneuropathy affects up to 80% of patients treated and constitutes a series adverse event, the occurrence of which may require anti-cancer therapy dose adjustment [69]
US$ 29.46
US$ 25.86
US$ 23.55
US$ 26.17
US$ 22.81
US$ 27.54
